Related Experiment Video
Updated: Dec 25, 2025
07:25
A Bioluminescent and Fluorescent Orthotopic Syngeneic Murine Model of Androgen-dependent and Castration-resistant Prostate Cancer
Published on: March 6, 2018
13.6K
Recent progress in treating advanced prostate cancer
1Division of Hematology/Oncology, Department of Medicine, Medical University of South Carolina, South Carolina, USA.
Current Opinion in Oncology
|March 27, 2020
Summary
Early use of novel androgen receptor inhibitors improves survival in advanced prostate cancer. Research also explores new targeted therapies, antibody-drug conjugates, and immunotherapy combinations for better treatment outcomes.
Area of Science:
- Oncology
- Urology
- Medical Research
Background:
- Advanced prostate cancer treatment has evolved significantly.
- Novel therapies offer new hope for patients with limited options.
Purpose of the Study:
- To review recent advances in treating advanced prostate cancer.
- To discuss the role of novel androgen receptor inhibitors.
- To explore future directions in prostate cancer therapy.
Main Methods:
- Literature review of recent randomized clinical trials.
- Analysis of data on existing and emerging prostate cancer treatments.
- Examination of ongoing clinical trials for novel agents.
Main Results:
- Early use of novel androgen receptor inhibitors with androgen deprivation therapy shows survival benefits.
- Optimal sequencing of current agents is under investigation.
- New genomically targeted therapies, antibody-drug conjugates, and immunotherapies are in development.
Conclusions:
- Novel androgen receptor inhibitors represent a significant advance in advanced prostate cancer care.
- Future treatment strategies will likely involve personalized approaches based on biomarkers and novel drug combinations.
Related Concept Videos
02:57Targeted Cancer Therapies
8.6K
The targeted cancer therapies, also known as “molecular targeted therapies,” take advantage of the molecular and genetic differences between the cancer cells and the normal cells. It needs a thorough understanding of the cancer cells to develop drugs that can target specific molecular aspects that drive the growth, progression, and spread of cancer cells without affecting the growth and survival of other normal cells in the body.
There are several types of targeted therapies against...
There are several types of targeted therapies against...
8.6K
02:56Treatment Resistant Cancers
3.6K
Cancer is the second leading cause of death in the United States. A cancer cell is genetically unstable and hence can mutate faster. They can also modify their microenvironment and escape immune surveillance. The difficulties in treating cancer are further compounded by the emergence of rapid resistance to anticancer drugs. The most common ways to attain resistance in cancer cells include alteration in drug transport and metabolism, modification of drug target, elevated DNA damage response, or...
3.6K
02:07Tumor Progression
7.1K
Tumor progression is a phenomenon where the pre-formed tumor acquires successive mutations to become clinically more aggressive and malignant. In the 1950s, Foulds first described the stepwise progression of cancer cells through successive stages.
Colon cancer is one of the best-documented examples of tumor progression. Early mutation in the APC gene in colon cells causes a small growth on the colon wall called a polyp. With time, this polyp grows into a benign, pre-cancerous tumor. Further...
Colon cancer is one of the best-documented examples of tumor progression. Early mutation in the APC gene in colon cells causes a small growth on the colon wall called a polyp. With time, this polyp grows into a benign, pre-cancerous tumor. Further...
7.1K
01:21Cancer Survival Analysis
590
Cancer survival analysis focuses on quantifying and interpreting the time from a key starting point, such as diagnosis or the initiation of treatment, to a specific endpoint, such as remission or death. This analysis provides critical insights into treatment effectiveness and factors that influence patient outcomes, helping to shape clinical decisions and guide prognostic evaluations. A cornerstone of oncology research, survival analysis tackles the challenges of skewed, non-normally...
590